Title: THE EVALUATION OF RESULTS OF CMV ANTIGENAEMIA ASSAYS IN BONE MARROW TRANSPLANT RECIPIENTS
Abstract: British Journal of HaematologyVolume 89, Issue 2 p. 427-429 Free Access THE EVALUATION OF RESULTS OF CMV ANTIGENAEMIA ASSAYS IN BONE MARROW TRANSPLANT RECIPIENTS Maria Koehler, Maria Koehler BMT Program, Children's Hospital of PittsburghSearch for more papers by this authorKirsten St. George, Kirsten St. George Division of Clinical Microbiology, University of Pittsburgh Medical Center, 3705 Fifth Avenue, Pittsburgh PA 15213-2583, U.S.A.Search for more papers by this authorCharles Rinaldo. Jr, Charles Rinaldo. Jr Division of Clinical Microbiology, University of Pittsburgh Medical Center, 3705 Fifth Avenue, Pittsburgh PA 15213-2583, U.S.A.Search for more papers by this author Maria Koehler, Maria Koehler BMT Program, Children's Hospital of PittsburghSearch for more papers by this authorKirsten St. George, Kirsten St. George Division of Clinical Microbiology, University of Pittsburgh Medical Center, 3705 Fifth Avenue, Pittsburgh PA 15213-2583, U.S.A.Search for more papers by this authorCharles Rinaldo. Jr, Charles Rinaldo. Jr Division of Clinical Microbiology, University of Pittsburgh Medical Center, 3705 Fifth Avenue, Pittsburgh PA 15213-2583, U.S.A.Search for more papers by this author First published: February 1995 https://doi.org/10.1111/j.1365-2141.1995.tb03324.xCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Gerna, G., Revello, M.G., Percivalle, E. & Morini, F. (1992) Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. Journal of Clinical Microbiology, 30, 1232– 1237. Gerna, G., Percivalle, E., Revello, M.G. & Morini, F. (1993) Correlation of quantitative human cytomegalovirus pp65-, p72-, and p150-antigenemia, viremia, and circulating endothelial giant cells with clinical symptoms and antiviral treatment in Immunocompromised patients. Clinical Diagnosis in Virology, 1, 47– 59. Gondo, H., Minematsu, T., Harada, M., Akashi, K., Hayashi, S., Taniguchi, S., Yamasaki, K., Shibuya, T., Takamatsu, Y., Teshima, T., Eto, T., Nagafuji, K., Mizuno, S.-I., Hosoda, K., Mori, R., Minamishima, Y. & Niho, Y. (1994) Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. British Journal of Haematology, 86, 130– 137. van den Berg, A. P., van der Berg, W., van Son, W.J., Anema, J., van der Giessen, M., Schirm, J., Tegzess, A.M. & Tbe, T.H. (1989) Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation: a report of 130 consecutive patients. Transplantation, 48, 991– 995. Citing Literature Volume89, Issue2February 1995Pages 427-429 ReferencesRelatedInformation